In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
--PIONEER AF-PCI results, evaluating XARELTO® (rivaroxaban) in people with non-valvular atrial fibrillation (NVAF) following percutaneous coronary intervention (PCI) with stenting, will be released during a Late-Breaking Clinical Trial session